Company profile: Context Matters
1.1 - Company Overview
Company description
- Provider of a next-generation data platform linking drug development and market data, helping pharmaceutical companies access and understand complex data. Offers Cortellis Regulatory Intelligence covering global health authority requirements for human healthcare products (drugs, biologics, medical devices, IVDs) and Cortellis CMC Intelligence for CMC documentation, reducing regulatory delays and rejections.
Products and services
- Context Matters Data Platform: A data-driven platform linking drug development and market data, enabling pharma teams to interpret complex, previously unquantified and unaggregated datasets for informed decision-making
- Cortellis Regulatory Intelligence: Delivers global coverage of health authority requirements for human healthcare products, including drugs, biologics, medical devices, and IVDs, with comprehensive, timely updates
- Cortellis CMC Intelligence: Offers CMC-specific access to pre- and post-approval documentation, simplifying access to global chemistry, manufacturing, and controls requirements and reducing the risk of regulatory delays and rejections
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Context Matters
Labstep
HQ: United Kingdom
Website
- Description: Provider of a data and inventory management platform that captures real-time scientific process data to create an internally shareable timeline of a lab's activity and connects notebooks, inventory, applications, and data in one collaborative workspace.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Labstep company profile →
Circuit Clinical
HQ: United States
Website
- Description: Provider of turnkey, end-to-end clinical trial solutions as an integrated research organization. Services include community research networks with traditional, hybrid, and decentralized visits; MD Prescreen led by research nurses and medical professionals; biospecimen collection; Phase I–IV trial management focused on diverse, community populations; and an IRO with direct EMR access to 2.5M+ participants.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Circuit Clinical company profile →
Reify Health
HQ: United States
Website
- Description: Provider of cloud-based tools for the clinical trial ecosystem, including OneStudyTeam, a platform connecting research sites, sponsors, patients, and other stakeholders to improve collaboration, enrollment, and trial management, and Care Access, an initiative integrating new-to-research physicians and practices to expand trial access for underserved communities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Reify Health company profile →
ProofPilot
HQ: United States
Website
- Description: Provider of a clinical experience platform designed to streamline recruitment, engagement, and retention for clinical study stakeholders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProofPilot company profile →
Metis Therapeutics
HQ: United States
Website
- Description: Provider of AI-driven integrated drug discovery and development, combining machine learning, quantum simulation, and high-throughput experimentation; high-throughput in vivo screening to discover LNPs targeting multiple organs; drug delivery and formulation platforms for small molecule and RNA drugs; CMC study design, manufacturing, regulatory filings; and project management for drug discovery and development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Metis Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Context Matters
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Context Matters
2.2 - Growth funds investing in similar companies to Context Matters
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Context Matters
4.2 - Public trading comparable groups for Context Matters
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →